Results 1 to 4 of 4
Page 1 of 1
TypeTitleAuthor(s)YearViews
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study
Proceedings/Conference:
Journal of Clinical Oncology
Publisher:
American Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Yau, TCC; Cheung, FY; Lee, F; Choo, SP; Wong, HYH; Toh, HC; Leung, AK; Chan, P; Yau, TK; Wong, J; Tang, YF; Lau, JSM; Cheung, TT; Fan, ST; Poon, RTP2013183
 
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
Journal:
Cancer Chemotherapy and Pharmacology
Publisher:
Springer. The Journal's web site is located at http://www.springer.com/medicine/oncology/journal/280
Kim, YH; Muro, K; Yasui, H; Chen, JS; Ryu, MH; Park, SH; Chu, KM; Choo, SP; Sanchez, T; DelaCruz, C; Mukhopadhyay, P; Lainas, I; Li, CP2012200
 
Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract)
Proceedings/Conference:
The 7th International Meeting Hepatocellular Carcinoma Eastern and Western Experiences, Paris, France, 14-15 January 2011
Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Toh, HC; Leung, AK; Wong, JS; Wong, S; Lau, J; Pang, RWC; Fan, ST; Poon, RTP2011415
 
Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma
Proceedings/Conference:
European Journal of Cancer Supplements
Publisher:
Elsevier BV. The Journal's web site is located at www.ejcancer.info/supplements
Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Lau, J; Wong, JS; Fan, ST; Poon, RTP2009154
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download